BioSpace News Archive

FDA

United Therapeutics And DEKA Announce FDA Clearance Of The Unity Subcutaneous Delivery System For Remodulin®

United Therapeutics Corporation and DEKA Research & Development Corp.

May 7, 2019
·
7 min read
Business

ADURO Teams With Bon Secours Mercy Health To Accelerate The Connection Between Well-Being And Precision Care For Modernized Healthcare

ADURO’s Digital Platform Connects the Well-being and Clinical Care Experience for Employees, Patients and Community

May 7, 2019
·
4 min read
Policy

Exact Imaging’s Abdominal Imaging Release Receives CE Mark Approval

New EV5C Abdominal Transducer and Color Flow and Power Doppler capabilities enable the ExactVu™ micro-ultrasound system to provide a complete men’s health urological imaging solution

May 7, 2019
·
2 min read
Job Trends

The Denver Post Names Syncroness Top 50 Winner of the Colorado Top Workplaces 2019 Award

Syncroness has been ranked in the Top 50 of Top Workplaces 2019 award by The Denver Post.

May 7, 2019
·
2 min read
Business

Sigilon Therapeutics Appoints Veteran Biotech Industry Leader John Cox to Board of Directors

Sigilon Therapeutics announced the appointment of distinguished biopharma executive John Cox, MBA, to its Board of Directors.

May 7, 2019
·
2 min read
Policy

Vizient Expresses Concern with FDA Policy on Naming of Biologic Medications

Vizient, Inc. submitted comments to the Food and Drug Administration in response to its published draft guidance on the nonproprietary naming of biological products.

May 7, 2019
·
2 min read
Genetown

Verve Therapeutics Founded to Protect Against Heart Disease Launches with $58.5 Million in Series A Funding Led by GV

Company to Develop Gene Editing Therapies to Permanently Reduce Risk of Coronary Artery Disease in Adults

May 7, 2019
·
10 min read
Business

Haemonetics 4th Quarter and Fiscal 2019 Earnings Release Available on Investor Relations Website

Haemonetics Corporation announced that financial results for its fourth quarter and fiscal year ended March 30, 2019 are available on its Investor relations website.

May 7, 2019
·
1 min read
Business

Regeneron Reports First Quarter 2019 Financial and Operating Results

Regeneron Pharmaceuticals, Inc. announced financial results for the first quarter of 2019 and provided a business update.

May 7, 2019
·
18 min read
Business

Henry Schein Reports Record First Quarter 2019 Financial Results from Continuing Operations

Q1 GAAP net income per diluted share from continuing operations of $0.78 versus prior-year GAAP net income per diluted share from continuing operations of $0.72

May 7, 2019
·
23 min read